EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of zoledronic acid for the elimination of disseminated tumor cells in a clinically relevant, spontaneously metastatic prostate cancer xenograft model

Lukas Clemens Böckelmann, Vera Freytag, Ann-Kristin Ahlers, Hanna Maar, Tobias Gosau, Anke Baranowsky, Rüdiger Schmitz, Klaus Pantel, Udo Schumacher, Marie-Therese Haider, Tobias Lange

Bone · 2023-06 · 171 · 116741

DOI: 10.1016/j.bone.2023.116741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2023-06. Verfasst von Lukas Clemens Böckelmann und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hambu…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Bone Density Conservation Agents, Bone Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBone Density Conservation AgentsBone NeoplasmsMaleHumansAnimalsMiceZoledronic AcidAndrogen AntagonistsHeterograftsImidazolesMice, SCIDDiphosphonatesTumor Microenvironment

Stichwörter der Autor:innen

BoneCastrationDTCMetastasisProstate cancerXenograft modelZoledronic acid

Substanzen

Zoledronic AcidAndrogen AntagonistsBone Density Conservation AgentsImidazolesDiphosphonates

Autor:innen und Institutionen

  • Institute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Oncology, Hematology and…
  • Institute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Institute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Anatomy I, Cancer Center…
  • Department of Osteology and Biomechanics, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Trauma Surgery and Orthopedics, University Medical Center Hamburg-…
  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Böckelmann, L. C., Freytag, V., Ahlers, A. K., Maar, H., Gosau, T., Baranowsky, A., Schmitz, R., Pantel, K., Schumacher, U., Haider, M. T., & Lange, T. (2023). Efficacy of zoledronic acid for the elimination of disseminated tumor cells in a clinically relevant, spontaneously metastatic prostate cancer xenograft model. Bone, 171, 116741. https://doi.org/10.1016/j.bone.2023.116741

Vancouver

Böckelmann LC, Freytag V, Ahlers AK, Maar H, Gosau T, Baranowsky A, et al. Efficacy of zoledronic acid for the elimination of disseminated tumor cells in a clinically relevant, spontaneously metastatic prostate cancer xenograft model. Bone. 2023;171:116741. doi:10.1016/j.bone.2023.116741

BibTeX
@article{Bckelmann2023,
  author = {Böckelmann, Lukas Clemens and Freytag, Vera and Ahlers, Ann-Kristin and Maar, Hanna and Gosau, Tobias and Baranowsky, Anke and Schmitz, Rüdiger and Pantel, Klaus and Schumacher, Udo and Haider, Marie-Therese and Lange, Tobias},
  title = {Efficacy of zoledronic acid for the elimination of disseminated tumor cells in a clinically relevant, spontaneously metastatic prostate cancer xenograft model},
  journal = {Bone},
  year = {2023},
  volume = {171},
  pages = {116741},
  doi = {10.1016/j.bone.2023.116741}
}
Kostenlos starten →